Peptides DB
Research-centric peptide and protocol reference hub
Study 6 of 9Hexarelin literaturebiorxiv-preprint · Observational2021

Investigating the impact of COVID-19 on performance and image enhancing drug use

During the COVID-19 pandemic, 45% of PIED users reported changes in their substance use patterns, but many did not alter their exercise habits significantly.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the hexarelin corpus
4
Preclinical
5
Observational · this one
0
Open-label
0
Randomised
0
Reviews

Summary and findings

The study assessed the impact of COVID-19 on performance and image enhancing drug (PIED) use among 60 consumers, with a mean age of 26.69. Participants completed a survey regarding their PIED use and exercise habits before and during lockdowns. The findings indicated changes in PIED use patterns during the pandemic, with some individuals ceasing use completely.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
45% reported a change in PIED use during lockdown, n=27.2021

Abstract

The authors’ words, as biorxiv-preprint supplied them

<title>Abstract</title> <p>Background Emerging research has suggested that the COVID-19 pandemic has had some impact on substance use patterns. The aim of the study was to conduct a rapid survey to assess the impact of COVID-19 on performance and image enhancing drug (PIED) use and training, and any subsequent negative physical or mental health outcomes. Methods During 2020, a convenience sample of 60 PIED consumers (mean age = 26.69; 68.3% located outside Australia) completed a quantitative anonymous online survey exploring how the coronavirus pandemic impacted patterns of PIED use and associated exercise habits. The survey was administered via the Qualtrics platform and distributed online through PIED forums as well as through the investigator's networks. Participants were asked about their PIED use and exercise habits prior to and during restricted movement ‘lockdowns’. Results Pre-COVID, the majority of the sample opted to ‘blast-cruise’ (an initial high dose, followed by a lower maintenance dose; 71.7%, n = 43). During lockdown, (45%, n = 27) reported a change in PIED use as a result of the restrictions. In light of health concerns during COVID-19, a majority of men (60%, n = 36) did not take any extra precautions relating to their PIED use. A subgroup of men ceased using PIEDs completely (16.7%, n = 10) with the majority (80%, n = 8) of that subgroup following post-cycle therapy (PCT) of some kind. Conclusions This study contributes to the emerging literature of the impact of the COVID-19 pandemic on substance use, specifically PIED use among men. The results suggest that the pandemic did influence the choice of PIEDs that participants consumed, although there was little disruption to patterns of exercise, an important aspect of PIED use. Of the men who did cease use completely, the majority reported little issue with PCT access; those who reported difficulty accessing PCT compounds indicated experience some mental health concerns related to ceasing their PIED use. Clinicians and those who come into contact with this group should be alert for any negative physical or mental health concerns resulting from disrupted or ceased PIED use.</p>

Elsewhere in the Hexarelin corpus

CGHSR agonism increases blood glucose but delays food intake in GHSR hyperresponsive rats.europepmc · 2026 · n=30 · Not reported in abstract.AnimalCHexarelin promotes the survival of retinal ganglion cells after optic nerve transection.europepmc · 2026 · Survival rates of RGC in saline, 25 μg/kg, 50 μg/kg, and 100 μg/kg hexarelin-treated hamsters were 51.2%, 62.4%, 68.5%, and 74.6%, respectively, in 7 days ONT.AnimalCGrowth Hormone-Releasing Peptide-6 (GHRP-6) Ameliorates Post-Infarct Ventricular Remodeling and Systolic Dysfunction in a Model of Permanent Coronary Ligation.europepmc · 2026 · Not reported in abstract.AnimalCHexarelin promotes the survival of retinal ganglion cells after optic nerve transection.PubMed · 2026 · Survival rates of RGCs were 74.6% at 100 μg/kg hexarelin after 7 days ONT.AnimalDSemantic Scholar search for HexarelinSemanticScholar · 2010CRevealing the interaction between peptide drugs and permeation enhancers in the presence of intestinal bile salts.PubMed · 2023 · Not reported in abstract.In vitro